Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (1): 63-64.
HUANG Xiaomei, NING Junkai, DAI Xubo*
Received:2018-10-25
Revised:2019-02-18
Online:2019-01-20
Published:2019-02-18
CLC Number:
HUANG Xiaomei, NING Junkai, DAI Xubo. One Case of Fanconi Syndrome and Low Phosphorus Osteomalacia Induced by Adefovir Dipivoxil Capsules[J]. Chinese Journal of Pharmacovigilance, 2019, 16(1): 63-64.
| [1] 周岳进,郑金莉,肖扬,等.国产阿德福韦酯治疗突变的慢性乙型肝炎疗效观察[J].东南国防医药,2006,8(5):330-331. [2] 田月洁,王金英,谢彦军,等.阿德福韦酯治疗乙肝致低血磷骨软化症的现状分析[J].中国药物警戒,2013,10(5):294-298. [3] 邱婷婷,张弨,陈丁丁. 6例药源性肾损伤案例报告及临床分析[J].临床药物治疗杂志,2017,15(6):63-68. [4] 党中勤,谢莉,袁帅强,等.乙肝患者长期服用阿德福韦酯致继发性范可尼综合征1例报道及预防[J].中医临床研究,2017,9(19):58-59. [5] 国家食品药品监督管理局.药品不良反应信息通报(第64期):警惕阿德福韦酯的低磷血症及骨软化风险[EB/OL].(2014-12-10) [2018-01-12].http://www.sda.gov.cn/WS01/CL0051/110621.html. [6] 张楠,邵明玮,黄爱,等.阿德福韦酯致低磷性骨软化症6例分析[J].中华内分泌代谢杂志,2013,29(5):414-416. [7] 刘莎,吴明,刘增娟.长期服用阿德福韦酯片致骨软化症1例[J].中国药物警戒,2017,14(9):570-571. [8] 孙晓方,张化冰,李新萍,等.阿德福韦酯导致低血磷性骨软化症一例并文献复习[J].中华内科杂志,2011,50(9):754-757. [9] 张帅,房舒舒,曹国颖.阿德福韦酯治疗乙肝致低磷血症及骨软化症文献汇总及数据分析[J].中国新药杂志,2015,24(15):1795-7800. [10] 邹羽真,胡扬,张波.阿德福韦酯致范可尼综合征1例及41例不良反应报道汇总分析[J].临床药物治疗杂志,2015,13(2):68-73. [11] 谢莉莉,田月洁,谢彦军,等.160例阿德福韦酯不良反应特征及骨软化的风险因素分析[J]. 中国药物警戒,2015,12(8):487-490. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
